Could cause temporary or reversible harm; serious harm is unlikely.
Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.
| Brand name | BUDESONIDE |
| Generic name | BUDESONIDE |
| Active ingredient(s) | BUDESONIDE |
| Distributed by / for | Ciple USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059 |
| NDC | 69097-319-86 |
| Full product label | Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd. Indore SEZ, Pithampur, India. Manufactured for: Ciple USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC# 69097-319-86 (pouch), 69097-319-87 (carton) |
| Recalling firm | Cipla USA, Inc. |
| Distribution | Distributed Nationwide in the USA |
| Quantity | 13,680 ampoules |
| Recall initiated | 2025-06-30 |
| Report date | 2025-07-30 |
| Recall completed | — |
| Recall number | D-0541-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Warren NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗